Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistanceDeus S. Ishengoma, Marian Warsame, Jovin Kitau et al.|The Lancet Infectious Diseases|2024Cited by 99
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest TanzaniaJonathan J. Juliano, Deus S. Ishengoma, David Giesbrecht et al.|medRxiv|2023Cited by 60
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional surveyJonathan J. Juliano, Deus S. Ishengoma, David Giesbrecht et al.|The Lancet Microbe|2024Cited by 40
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers studyDeus S. Ishengoma, Marian Warsame, Celine I. Mandara et al.|medRxiv|2024Cited by 22
Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland TanzaniaDeus S. Ishengoma, Abebe A. Fola, Celine I. Mandara et al.|Malaria Journal|2024Cited by 16